Sumitomo Pharma Co Ltd
DUS:DPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sumitomo Pharma Co Ltd
DUS:DPM
|
JP |
|
Bank Pan Indonesia Tbk PT
F:PTQ
|
ID |
|
F
|
Freeport-McMoRan Inc
BMV:FCX
|
US |
|
U
|
Unique Fire Holdings Bhd
KLSE:UNIQUE
|
MY |
|
P
|
Phoenix Mecano AG
F:PXM
|
CH |
|
C
|
CJ Corp
KRX:001045
|
KR |
|
I
|
Interpublic Group of Companies Inc
F:IPG
|
US |
|
P
|
Pioneer Property Group ASA
OSE:PPG
|
NO |
|
H
|
Harley-Davidson Inc
F:HAR
|
US |
|
Blue Line Protection Group Inc
OTC:BLPG
|
US |
|
ContextVision AB
OSE:CONTX
|
SE |
|
DRDGOLD Ltd
OTC:DRDGF
|
ZA |
|
M
|
Mintra Holding AS
F:N0D
|
NO |
|
A
|
Allison Transmission Holdings Inc
F:1A7
|
US |
|
I
|
Impinj Inc
F:27J
|
US |
|
E
|
Electricite de France SA
F:E2F
|
FR |
|
T
|
Taoka Chemical Co Ltd
TSE:4113
|
JP |
|
O
|
Onward Technologies Ltd
BSE:517536
|
IN |
Wall St Price Targets
DPM Price Targets Summary
Sumitomo Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for DPM is 10.525 EUR with a low forecast of 7.949 EUR and a high forecast of 14.324 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DPM's stock price target?
Price Target
10.525
EUR
According to Wall Street analysts, the average 1-year price target for DPM is 10.525 EUR with a low forecast of 7.949 EUR and a high forecast of 14.324 EUR.
What is the Revenue forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-83%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is -83%.
What is the Pre-Tax Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is -4%.
What is the Net Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-14%
Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is -14%.
